Bayer AG

EU Legislative Interests

Policy areas related to pharmaceutical, crop protection, seeds and corporate legislations and regulations as well as policies in the area of trade, industry, intellectual property, environmental protection, chemical policy, agricultural policy, digital policy, taxation, innovation and research, development policy and pesticide regulations: 1. A Vision for Agriculture and Food (Farm to Fork Strategy) 2. CAP post-2027 3. EU Biodiversity Strategy for 2030 4. Chemicals Strategy for Sustainability 5. Zero Pollution Action Plan 6. Soil Monitoring and Resilience Law 7. EU Enlargement Strategy 8. Sustainable Products Initiative 9. Sustainable Food System Framework 10. Protection of groundwater & Environmental Quality Standards 11. Packaging and Packaging Waste 12. Amendment of Water Framework Directive 13. Urban Waste Water Treatment Directive (recast) 14. Carbon Removal Certification Framework 15. Revision of EU Climate Law (2040 target) 16. Plant Reproductive Material 17. Plant Protection Products & labelling 18. Industrial Emissions Directive (recast) 19. Multiannual Financial Framework 2028–2034 20. EU General Pharmaceuticals Legislation 21. European Health Data Space 22. Farm Sustainability Data Network 23. Health Technology Assessment 24. Safe and Sustainable by Design Framework 25. Revision of Water Directives package 26. Titanium Dioxide (E171) ban 27. EU Beating Cancer Plan 28. REACH revision 29. PFAS restriction – REACH Annex XV restriction proposal (ECHA, 2023) 30. CLP Regulation revision 31. EU Taxonomy Regulation 32. European Data Governance Act 33. EU Intellectual Property Package 34. EU Artificial Intelligence Act 35. Prohibition of export of banned chemicals 36. Maximum residue levels of pesticides 37. European Climate Resilience & Risk Management Initiative 38. Nature Restoration Law 39. EU Deforestation Regulation 40. CSRD/CSDDD alignment directive 41. Amendment of Industrial Emissions Directive 42. ESG Rating Agencies Regulation 43. Green Claims Directive 44. Revised Product Liability Directive 45. Forced Labour Regulation 46. EU Trade Policy Review / FTAs 47. EU Economic Security Strategy 48. European Biotech Act I 49. On-farm sustainability compass 50. PPP record-keeping implementing act 51. EU Safe Hearts Plan 52. Common data platform on chemicals 53. Re-attribution of tasks among EU chemicals agencies 54. EU Critical Medicines Act 55. Unilateral trade measures / FDI screening 56. Revision of vitamins & minerals Directive 57. New Genomic Techniques 58. EU-Mercosur safeguard regulation 59. Omnibus VII – Food and Feed Safety 60. Omnibus I (CSRD, CSDDD, Taxonomy) 61. Roadmap towards Nature Credits 62. EU Bioeconomy Strategy 63. European Water Resilience Strategy 64. Revision of Implementing Regulation (EU) 2022/996 65. Adjustment of customs duties on US goods 66. EU Dangerous Goods Regulation 67. Directive on deliberate release of Genetically Modified Organisms and the recent proposal to amend it 68. GM food and feed and its implementing regulation (EU) No. 503/2013 69. Plant Reproductive Material – proposal for a regulation replacing several directives 70. Delegated regulation supplementing regulation 2024/3012 by establishing methodologies for carbon farming activities 71. European Climate Resilience and Risk Management – Integrated Framework 72. Omnibus VI - Chemicals 73. Omnibus VII - Digital 74. European Health Data Space Regulation

Communication Activities

Bayer accompanies, to a varying degree, all of its political initiatives and aims as well as their implementation with activities in the field of communication and public relations. In the last year this included engagement with media on innovation and science, as well as events in cooperation with other organizations. Bayer has set for itself highest ethical standards on engagement with media and makes its positions transparent to the public. Concerning regular series of communication activities Bayer is sponsoring content and events organised by Politico in the framework of the "Drive sustainable progress" campaign. Further information can be found here: https://www.politico.eu/sponsored-content/drive-sustainable-progress-hub/ Other activities supported or organised in 2025: EFPIA - Europe's Choice Campaign Bayer - Back to Growth event in Brussels

Interests Represented

Promotes their own interests or the collective interests of their members

Member Of

Bayer is on the EU level directly member of the following associations, networks or platforms: Business Europe European Chemical Industry Council (CEFIC) FluoroProducts and PFAS for Europe (FPP4EU) European Federation of Pharmaceutical Industries Association (EFPIA) the Association of the European Self-Medication Industry (AESGP) CropLife Europe (CLE) Euroseeds Cosmetics Europe DIGITALEUROPE European Justice Forum Food Supplements Europe MedTech Europe European Coordination Committee of the Radiological, Electromedical and Healthcare IT Industry (COCIR) Nuclear Medicines Europe (NMEU) The Alliance for Regenerative Medicine (ARM) European Biostimulants Council (EBIC) MedTech & Pharma Platform European Health Summits (EBS) The Public Affairs Council The Ad Hoc Partnership Limited Conseil de Cooperation Economique (CCE) The company is also supporting a network of stakeholders in the area of innovation, health, trade, agricultural and chemical policy, which includes: Farm Europe Plants for the Future European Technology Platform (Plant ETP) Friends of the Countryside The Glyphosate Renewal Group Chemleg European Notification Panel (ENP) EURORDIS (European Organisation for Rare Diseases) EIT Food EU Critical Medicines Alliance EU Critical Chemicals Alliance The Ad-hoc Annex IX Industry Coalition

Organisation Members

The Bayer EU Public Affairs office represents Bayer AG and all its affiliates at EU level. Further information can be found here: https://www.bayer.com/

Additional Information

Transparency is a top priority for Bayer. We are committed to strengthen trust by making information accessible from a whole range of areas including our political engagement. We have established our own code of conduct for responsible lobbying (publicly available on our website) many years ago and declare our lobbying costs in our annual report. We furthermore publish an annual global Political Advocacy Transparency Report. Bayer in addition to the costs of its EU Public Affairs Office, included the expenses of its business divisions providing e.g. background research, position papers, political work within European associations and visits to Brussels related to activities falling under the scope of the register. Following the rules of the Transparency Register, Bayer included all relevant costs for intermediary contracts falling under the scope and definition of the register. Relevant shares of communication activities as described under heading 9 are included in the total annual costs declared. Bayer is a member of various trade associations, independently reporting in the transparency register. Membership fees to these trade associations are used for a wide array of activities, including the independent representation of industry interests. The 2025 estimates are in some limited cases not yet available and will be provided in due time. It should be noted that these fees are being also reported in the budgets of the trade associations, thus effectively resulting in a double reporting.